Direkt zum Inhalt
Merck
  • Unjamming overcomes kinetic and proliferation arrest in terminally differentiated cells and promotes collective motility of carcinoma.

Unjamming overcomes kinetic and proliferation arrest in terminally differentiated cells and promotes collective motility of carcinoma.

Nature materials (2019-07-25)
Andrea Palamidessi, Chiara Malinverno, Emanuela Frittoli, Salvatore Corallino, Elisa Barbieri, Sara Sigismund, Galina V Beznoussenko, Emanuele Martini, Massimiliano Garre, Ines Ferrara, Claudio Tripodo, Flora Ascione, Elisabetta A Cavalcanti-Adam, Qingsen Li, Pier Paolo Di Fiore, Dario Parazzoli, Fabio Giavazzi, Roberto Cerbino, Giorgio Scita
ZUSAMMENFASSUNG

During wound repair, branching morphogenesis and carcinoma dissemination, cellular rearrangements are fostered by a solid-to-liquid transition, known as unjamming. The biomolecular machinery behind unjamming and its pathophysiological relevance remain, however, unclear. Here, we study unjamming in a variety of normal and tumorigenic epithelial two-dimensional (2D) and 3D collectives. Biologically, the increased level of the small GTPase RAB5A sparks unjamming by promoting non-clathrin-dependent internalization of epidermal growth factor receptor that leads to hyperactivation of the kinase ERK1/2 and phosphorylation of the actin nucleator WAVE2. This cascade triggers collective motility effects with striking biophysical consequences. Specifically, unjamming in tumour spheroids is accompanied by persistent and coordinated rotations that progressively remodel the extracellular matrix, while simultaneously fluidizing cells at the periphery. This concurrent action results in collective invasion, supporting the concept that the endo-ERK1/2 pathway is a physicochemical switch to initiate collective invasion and dissemination of otherwise jammed carcinoma.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Doxycyclin -hyclat
Sigma-Aldrich
Monoklonaler Anti-Vinculin-Antikörper in Maus hergestellte Antikörper, clone hVIN-1, ascites fluid
Sigma-Aldrich
Monoklonaler Anti-α-Tubulin-Antikörper in Maus hergestellte Antikörper, ascites fluid, clone B-5-1-2
Sigma-Aldrich
Phalloidin-Tetramethylrhodamin B-Isothiocyanat aus Amanita phalloides, sequence from Amanita phalloides(synthetic: peptide sequence)
Sigma-Aldrich
Mitomycin C aus Streptomyces caespitosus, powder, contains NaCl as solubilizer
Sigma-Aldrich
Phalloidin-Fluoresceinisothiocyanat-Konjugat aus Amanita phalloides, sequence Amanita phalloides(synthetic: peptide sequence)
Sigma-Aldrich
Dynasore Hydrat
Sigma-Aldrich
5-(N-Ethyl-N-isopropyl)amilorid
Sigma-Aldrich
CK-666, ≥98% (HPLC), powder
Sigma-Aldrich
MEK1/2-Inhibitor III, The MEK1/2 Inhibitor III, also referenced under CAS 391210-10-9, controls the biological activity of MEK1/2. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.
Sigma-Aldrich
Tyrphostin AG 1478, ≥98%
Sigma-Aldrich
Anti-Phospho-WAVE2(Ser343)-Antikörper, from rabbit, purified by affinity chromatography